Incidence of anemia in children with solid tumors or Hodgkin disease

Area of Science:

• Pediatric Oncology
• Hematology
• Cancer Epidemiology

Background:

• Anemia is a common hematologic abnormality in children undergoing cancer treatment.
• The incidence of anemia at diagnosis for various pediatric cancers has not been previously reported.
• Understanding anemia incidence is crucial for managing pediatric cancer patients.

Purpose of the Study:

• To determine the incidence of anemia in children newly diagnosed with specific cancers.
• To establish a baseline for anemia prevalence in pediatric oncology.
• To prompt further investigation into the clinical significance of anemia in this population.

Main Methods:

• Retrospective review of medical records from two pediatric oncology centers.
• Inclusion of patients aged 1-18 years with newly diagnosed neuroblastoma, rhabdomyosarcoma, Hodgkin disease, Ewing sarcoma, or osteosarcoma.
• Analysis of hemoglobin levels at diagnosis using Centers for Disease Control and Prevention (CDC) age- and sex-specific anemia criteria.

Main Results:

• Data from 405 pediatric cancer patients were analyzed.
• Anemia incidence ranged from 51% to 74% across different cancer diagnoses at the time of diagnosis.
• A high prevalence of anemia was observed in newly diagnosed pediatric cancer patients.

Conclusions:

• Anemia is highly prevalent in children at the time of diagnosis for common pediatric cancers.
• The incidence of anemia in this population is significant and warrants attention.
• Further research is needed to understand the long-term complications and clinical significance of anemia in pediatric cancer patients, including its impact on quality of life.